Australia markets open in 4 hours 41 minutes

OPKO Health, Inc. (OPK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2601+0.0401 (+3.29%)
As of 03:19PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 857.30M
Enterprise value 1.09B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.07
Price/book (mrq)0.62
Enterprise value/revenue 1.26
Enterprise value/EBITDA -16.61

Trading information

Stock price history

Beta (5Y monthly) 1.84
52-week change 3-20.26%
S&P500 52-week change 323.10%
52-week high 32.2400
52-week low 30.8500
50-day moving average 31.1048
200-day moving average 31.3802

Share statistics

Avg vol (3-month) 38.9M
Avg vol (10-day) 33.76M
Shares outstanding 5696.99M
Implied shares outstanding 6696.99M
Float 8331.18M
% held by insiders 152.41%
% held by institutions 125.29%
Shares short (15 Apr 2024) 478.03M
Short ratio (15 Apr 2024) 46.23
Short % of float (15 Apr 2024) 421.06%
Short % of shares outstanding (15 Apr 2024) 411.19%
Shares short (prior month 15 Mar 2024) 4102.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -21.87%
Operating margin (ttm)-37.96%

Management effectiveness

Return on assets (ttm)-4.73%
Return on equity (ttm)-12.80%

Income statement

Revenue (ttm)863.49M
Revenue per share (ttm)1.15
Quarterly revenue growth (yoy)-1.90%
Gross profit (ttm)N/A
EBITDA -52.76M
Net income avi to common (ttm)-188.86M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)95.88M
Total cash per share (mrq)0.14
Total debt (mrq)326.58M
Total debt/equity (mrq)23.51%
Current ratio (mrq)1.55
Book value per share (mrq)1.80

Cash flow statement

Operating cash flow (ttm)-28.2M
Levered free cash flow (ttm)16.65M